Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Hepatocellular

Explore clinical trials studying Carcinoma, Hepatocellular. Study availability and eligibility vary by location and protocol.

2,099 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Hepatocellular trial results

Active, Not Recruiting

A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma

NCT05022927

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Chiba University Hospital Chiba, Japan
  • National Cancer Center Hospital East Kashiwa, Chiba, Japan
  • Kanagawa Cancer Center Yokohama, Kanagawa, Japan
  • Kindai University Hospital Sayama, Osaka, Japan
View Trial Details
Active, Not Recruiting

Pembrolizumab and Lenvatinib for Resectable Hepatocellular Carcinoma

NCT05389527

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • Zhongshan hospital Shanghai, Shanghai Municipality, China
  • Eastern Hepatobiliary Surgery Hospital Shanghai, Shanghai Municipality, China
  • Ruijin Hospital Shanghai, Shanghai Municipality, China
  • The first affiliated hospital, Yat-sen university Guangzhou, China
View Trial Details
Active, Not Recruiting

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

NCT03836352

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +39 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Cedars Sinai Medical Center: Samuel Oschin Comprehensive Cancer Center Los Angeles, California, United States
  • Boca Raton Regional Hospital, Lynn Cancer Institute Boca Raton, Florida, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View all 23 locations
View Trial Details

Related conditions